George Bakris, MD

George Bakris, MD
 

Professor of Preventive Medicine
Vice-Chairman, Department of Preventive Medicine
Rush Medical College
Chicago, Illinois


What was the physiological, safety, and compliance-focused rationale for combining basal insulin plus GLP-1 RA into a fixed ratio formulation? How would this approach achieve pan-glycemic (FBG and PPG) control?

What was the physiological, safety, and compliance-focused rationale for combining basal insulin plus GLP-1 RA into a fixed ratio formulation? How would this approach achieve pan-glycemic (FBG and PPG) control?

From an HA1c control perspective, what is the advantage of using GLP-1 RAs in combination with long-acting insulin rather than as stand-alone therapy or as add-on to metformin?

From an HA1c control perspective, what is the advantage of using GLP-1 RAs in combination with long-acting insulin rather than as stand-alone therapy or as add-on to metformin?

Who do you believe would benefit from a fixed ratio combination of a GLP-1 RA with long-acting insulin?

Who do you believe would benefit from a fixed ratio combination of a GLP-1 RA with long-acting insulin?

What are the cardiovascular effects of GLP-1 RAs?

What are the cardiovascular effects of GLP-1 RAs?